cancer clinical trials in boston, MA
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Massachusetts General Hospital Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Relapsed/Refractory Chronic Lymphocytic Leukemia, Relapsed/Refractory Non Hodgkin's Lymphoma, Hodgkins Disease, Relapsed Refractory Multiple Myeloma
|
Brigham and Women's Hospital
Boston, Massachusetts 02115 Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
|
Dana Farber Cancer Institute and Children's Hospital
Boston, Massachusetts 02215-5450 Acute Myeloid Leukemia
|
Dana-Farber Cancer Institute
Boston, Massachusetts 02115 Glioblastoma Multiforme
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Thyroid Cancer
|
Dana Farber Cancer Institute
Trial Locations Dana Farber Cancer Institute Brigham & Women's Hospital Refractory TdT-Positive Leukemia
|
Massachusetts General Hospital
Trial Locations Massachusetts General Hospital Dana Farber Cancer Institute Secondary Acute Myeloid Leukemia (Secondary AML, sAML)
|
Beth Israel Deaconess Medical Centre
Boston, Massachusetts 02215 Deep Vein Thrombosis, Pulmonary Embolism
|
ImClone Investigational Site
Boston, Massachusetts 02135 Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Hodgkin Lymphoma
|
Dana Farber Cancer Institute
Boston, Massachusetts 02115 Myelofibrosis
|
Dana Farber Cancer Institute (and Massachusetts General)
Boston, Massachusetts 02115 Multiple Myeloma
|
1200.36.0002 Boehringer Ingelheim Investigational Site
Boston, Massachusetts Glioma
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Massachusetts General Hospital Dana Farber Cancer Institute Metastatic Castration-resistant Prostrate Cancer (mCRPC), Renal Cell Carcinoma (RCC), Metastatic Melanoma (MEL), Non-small Cell Lung Cancer (NSCLC)
|
Floating Hospital for Children at Tufts Medical Center
Boston, Massachusetts 02111 Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Angioimmunoblastic T-cell Lymphoma, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, Essential Thrombocythemia, Extramedullary Plasmacytoma, Intraocular Lymphoma, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Long-term Effects Secondary to Cancer Therapy in Children, Mast Cell Leukemia, Meningeal Chronic Myelogenous Leukemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Primary Myelofibrosis, Primary Systemic Amyloidosis, Progressive Hairy Cell Leukemia, Initial Treatment, Prolymphocytic Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Stage 0 Chronic Lymphocytic Leukemia, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Hodgkin Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, T-cell Large Granular Lymphocyte Leukemia, Unspecified Childhood Solid Tumor, Protocol Specific, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Untreated Hairy Cell Leukemia, Waldenström Macroglobulinemia
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Tufts Medical Center Mantle Cell Lymphoma
|
Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute
Boston, Massachusetts 02115 Metastatic Renal Cell Carcinoma
|
Dana Farber Cancer Institute Hematology / Oncology
Boston, Massachusetts 02115 Classical Hodgkin's Lymphoma (i.e. Nodular Sclerosing, Mixed-cellularity, Lymphocyte-rich, Lymphocyte-depleted)
|
Site Reference ID/Investigator# 63588
Trial Locations Site Reference ID/Investigator# 63588 Site Reference ID/Investigator# 63591 Hematologic Cancer
|
St. Elizabeth's Medical Center
Boston, Massachusetts 02135-2997 Lung Cancer
|
Massachusetts General Hospital Cancer Center
Boston, Massachusetts 02114 Ovarian Stromal Cancer
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Renal Cell Carcinoma
|
Massachusetts Eye & Ear Infirmary
Boston, Massachusetts 02114 Choroidal Melanoma
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Malignant Glioma
|
Beth-Israel Deaconess Medical Center
Boston, Massachusetts Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer
|
Massachusetts General Hospital Cancer Center
Boston, Massachusetts 02114 Melanoma
|
Massachusetts General Hospital
Boston, Massachusetts 02114-2617 Lung Cancer, Non Small Cell Lung Cancer
|
Dana-Farber Cancer Institute
Trial Locations Dana-Farber Cancer Institute Floating Hospital for Children at Tufts Medical Center Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
|
Dana-Farber Cancer Institute
Trial Locations Dana-Farber Cancer Institute Beth-Israel Deaconess Medical Center Prostate Cancer
|
Dana Farber Cancer Institute Hematology / Oncology
Boston, Massachusetts 02115 Leukemia
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Renal Cell Carcinoma, Kidney Cancer
|
Beth Israel Deaconess Medical Center
Trial Locations Beth Israel Deaconess Medical Center Massachusetts General Hospital Cancer Center Dana-Farber Cancer Institute Boston Medical Center Brigham and Women's Hospital Tufts Medical Center Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
|
Beth Israel Deaconess Medical Center
Boston, Massachusetts 02215 Mucosal Melanoma, Acral Melanoma, Melanoma
|